Answers are grounded in this paper and cite their sources.
Examines risk factors for head and neck dermatitis in patients with atopic dermatitis, suggesting possible predictors.
Summary 11.5% of patients experienced the occurrence/aggravation of HND during dupilumab treatment. Comorbid allergic rhinitis and baseline total IgE ≥ 3000 kU/L are potential risk factors for DAHND.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: